logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Pharmaceutical company Ysbang (09885.HK) spent HKD 1.0231 million to repurchase 100,000 shares on August 21st.

date
21/08/2025
Wisdom Finance APP news, Pharmacist Help (09885.HK) announced that on August 21, 2025, it will spend 1.0231 million Hong Kong dollars to repurchase 100,000 shares.
Latest
2 m ago
AT&S (688472.SH) released its first half year results, with a net profit attributable to shareholders of 731 million yuan, a year-on-year decrease of 41.01%.
3 m ago
Yiwei Lithium Energy (300014.SZ) released its first half-year financial results, with a net profit attributable to the parent company of 1.605 billion yuan, a decrease of 24.9%
3 m ago
The Baltic Dry Index hit a one-month low due to a decrease in Cape-sized vessel freight rates.
4 m ago
Chilean peso falls as a result of reports of the resignation of the finance minister, leading to a decline in emerging market currencies.
5 m ago
The Polish Ministry of Finance plans to increase the corporate tax rate for banks to 30% by 2026.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.